^
+ Follow GOETTINGEN Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 180239
                    [Title] => Clot-dissolving therapy stops ‘submassive PE’
                    [Summary] => INGELHEIM, Germany – Clinical trial results published last week in the New England Journal of Medicine demonstrated that the clot-dissolving agent alteplase (Actilyse tPA) can prevent the clinical deterioration of patients with submassive pulmonary embolism.

[DatePublished] => 2002-10-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
GOETTINGEN
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 180239
                    [Title] => Clot-dissolving therapy stops ‘submassive PE’
                    [Summary] => INGELHEIM, Germany – Clinical trial results published last week in the New England Journal of Medicine demonstrated that the clot-dissolving agent alteplase (Actilyse tPA) can prevent the clinical deterioration of patients with submassive pulmonary embolism.

[DatePublished] => 2002-10-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with